Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Parkinson's Disease

  Free Subscription


11.08.2025

1 Ann Neurol
1 Exp Neurol
2 Mov Disord
1 Nat Neurosci
1 Neurologia (Engl Ed)
2 Neurology
1 Neurosci Lett
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Rev Neurol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. VAN DUIJVENBODEN S, Ramirez J, Scheurink J, Darweesh SKL, et al
    Heart Rate Profiles During Exercise and Incident Parkinson's Disease.
    Ann Neurol. 2025 Aug 2. doi: 10.1002/ana.70010.
    PubMed         Abstract available


    Exp Neurol

  2. MIN X, Du Z, Wei J, Yuan Z, et al
    Pyridoxal phosphate inhibits alpha-synuclein-induced ferroptosis by activating GOT1 to enhance the methionine salvage pathway in Parkinson's disease.
    Exp Neurol. 2025;393:115411.
    PubMed         Abstract available


    Mov Disord

  3. KRAUSS J, Upadhyay N, Purrer V, Borger V, et al
    Probabilistic Mapping of Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Thalamotomy Targets in Essential Tremor and Tremor-Dominant Parkinson's Disease: Insights from a German Cohort.
    Mov Disord. 2025 Aug 8. doi: 10.1002/mds.70003.
    PubMed         Abstract available

  4. ZARKALI A, Thomas G, Paterson R, Hannaway N, et al
    Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space (DTI-ALPS), is Linked to Poor Cognitive Outcomes in Parkinson's Disease.
    Mov Disord. 2025 Aug 7. doi: 10.1002/mds.30325.
    PubMed         Abstract available


    Nat Neurosci

  5. MARUTANI E, Miranda M, Durham TJ, Kim SH, et al
    Hypoxia ameliorates neurodegeneration and movement disorder in a mouse model of Parkinson's disease.
    Nat Neurosci. 2025 Aug 6. doi: 10.1038/s41593-025-02010.
    PubMed         Abstract available


    Neurologia (Engl Ed)

  6. ZHANG Y, Lin Y, Zhong CCW, Ho FF, et al
    Methodological quality of systematic reviews on treatments for Parkinson's disease: A cross-sectional study.
    Neurologia (Engl Ed). 2025;40:507-517.
    PubMed         Abstract available


    Neurology

  7. GONZALEZ-ESCAMILLA G, Groppa S
    MRI-Based Evidence of Regular Physical Activity's Impact on Brain Networks for Modifying Disease Courses in Parkinson Disease.
    Neurology. 2025;105:e214059.
    PubMed        

  8. DIAZ-GALVAN P, Franco-Rosado P, Silva-Rodriguez J, Castro-Labrador S, et al
    Association of Physical Exercise With Structural Brain Changes and Cognitive Decline in Patients With Early Parkinson Disease.
    Neurology. 2025;105:e213932.
    PubMed         Abstract available


    Neurosci Lett

  9. WANG J, Hou J, Du M, Hou X, et al
    The mechanism of alpha-lipoic acid regulating dopaminergic neuronal damage in Parkinson's disease through the Nrf2/HMOX1 pathway.
    Neurosci Lett. 2025 Aug 3:138338. doi: 10.1016/j.neulet.2025.138338.
    PubMed         Abstract available


    PLoS One

  10. WANG H, Feng L, He L, Liu N, et al
    Bioinformatics analysis to explore biomarkers and mechanisms of action associated with endoplasmic reticulum stress and ferroptosis in Parkinson's disease.
    PLoS One. 2025;20:e0328682.
    PubMed         Abstract available

  11. POLINSKI NK, Puolivali J, Rauhala L, Stenius TK, et al
    Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson's disease-related phenotypes in a novel humanized rat model.
    PLoS One. 2025;20:e0329823.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  12. FERGUSON SM
    Derailed degradation: LRRK2-dependent exocytosis in Parkinson's disease.
    Proc Natl Acad Sci U S A. 2025;122:e2515758122.
    PubMed        


    Rev Neurol

  13. GARCIA-AGUA SOLER N, Garcia Trujillo L, Garcia-Ruiz AJ
    Cost of Quality of Life in Advanced Parkinson's Disease: Efficient Strategies for Disease Assessment.
    Rev Neurol. 2025;80:33482.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.